NISHA BHARDWAJ: Open Payments
NPI 1093407942 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 42 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $305 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 24 | $301 |
| ViiV Healthcare Company | 9 | $217 |
| Theratechnologies Inc. | 2 | $60 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| ABBVIE INC. | 1 | $23 |
| Shionogi Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
Products named: CABENUVA, APRETUDE, EGRIFTA, VOWST, DOVATO, PIFELTRO, AVYCAZ, Fetroja.
Industry payments across MD — which companies pay providers there.
